Management of Refractory Anxiety on Multi-Drug Regimen

Medication Dosing and Adjustment

• The American Academy of Family Physicians recommends that benzodiazepines, such as clonazepam, should not be used for long-term anxiety management due to dependence risk and the availability of more effective alternatives in patients with anxiety disorders 4
• The American Academy of Family Physicians suggests that lexapro 20mg is already at maximum recommended dose for anxiety disorders, and higher doses do not consistently provide additional benefit in patients with generalized anxiety disorder 1, 2, 3

Alternative Therapies

• The Mayo Clinic recommends considering switching from hydroxyzine to pregabalin, which has stronger evidence for anxiety disorders, starting at 75mg twice daily and titrating to 150-300mg twice daily in patients who do not respond to quetiapine optimization 5
• The Mayo Clinic suggests reassessing the SSRI choice, as some patients may respond better to SNRIs like venlafaxine or duloxetine for anxiety with prominent somatic symptoms in patients with treatment-resistant anxiety 5, 6

Safety Considerations

• The Annals of Oncology warns to avoid combining quetiapine with additional benzodiazepines at high doses due to risk of oversedation and respiratory depression in patients with anxiety disorders 7
• The Journal of the American Academy of Child and Adolescent Psychiatry recommends monitoring for serotonin syndrome when combining multiple serotonergic agents, such as escitalopram with quetiapine, though risk is low at these doses in patients with anxiety disorders 8, 9